Molecular Partners AG at JPMorgan Healthcare Conference (Virtual) Transcript
Good morning, and good afternoon. Welcome to the fourth day of the JPMorgan Healthcare Conference. I'm Richard Vosser, European pharma analyst at JPMorgan. And it's my great pleasure to introduce the CEO of Molecular Partners, Patrick Amstutz, for this presentation.
Before I hand over to Patrick, just a few remarks on Q&A. You can access the Q&A section of the website at any time to ask your question, and then I will read that out for you at the appropriate time during the Q&A portion of this presentation.
With that, I'd like to say a great welcome to Patrick. Patrick, over to you.
Thanks, Richard, and thanks for the introduction. And I hear that I don't control the slides, so you do that. So I will also refer to which slide I'm on that you can push the slides to where I am presenting.
I think, obviously, this is a very special JPMorgan. And in
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
